drugset / Trial / NCT01224236

Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants

NCT01224236

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.

Timeline

Start
2010-07
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject elemental iron Unknown 2 mg/kg

Indications